On this page
⚠ Educational content only Not medical or genetic advice. Speak with a healthcare provider or genetic counsellor before acting on anything here.

ATP5MD

ATP synthase membrane subunit k

Chromosome 10q24.33 Various HGNC:30889 Tier C
Why it's called ATP5MD
ATP synthase Membrane subunit D
Named for its role as a membrane subunit of ATP synthase complex V.
ATP5MD 10q24.33 p arm q arm 10

ATP5MD is located on the long (q) arm of chromosome 10, at band 10q24.33. Arm ratio per GRCh38 - banding schematic.

Explore chromosome 10 in the library →

Available at Jeen Health

Clinical tests that include this

Overview

ATP5MD encodes ATP synthase membrane subunit k, a component of the mitochondrial ATP synthase complex. This molecular machine harnesses the flow of protons across the inner mitochondrial membrane to synthesise ATP, which powers cellular activities from muscle contraction to nerve signalling. The ATP5MD protein is one of several membrane-spanning subunits that anchor the enzyme complex within the mitochondrial inner membrane. Mitochondrial ATP synthase comprises approximately 16 different protein subunits organised into two main functional regions: a membrane-embedded portion that forms a proton channel, and a catalytic region that synthesises ATP. The protein encoded by ATP5MD belongs to the membrane-embedded component, where it helps maintain the structural arrangement necessary for efficient energy conversion.

What the gene does

The ATP5MD protein forms part of the membrane sector of ATP synthase, which acts as a rotary motor driven by the movement of protons. As protons flow through channels in the membrane-embedded portion of the complex, they cause a central stalk to rotate. This mechanical rotation drives conformational changes in the catalytic region, enabling the enzyme to combine adenosine diphosphate (ADP) with inorganic phosphate to form ATP. The membrane subunits, including ATP5MD, contribute to creating the proton pathway and stabilising the overall architecture of the complex during this rotational catalysis. Each human cell contains hundreds to thousands of mitochondria, and each mitochondrion harbours multiple copies of ATP synthase. This redundancy reflects the critical importance of continuous ATP production, as cells require constant energy supply to maintain ion gradients, synthesise macromolecules, and perform specialised functions. The efficiency of ATP synthase depends on the precise assembly and positioning of all its constituent subunits within the inner mitochondrial membrane.

Video: Genetics 101

Chromosome location

The ATP5MD gene is located on the long arm of chromosome 10 at position 10q24.33. This chromosomal region contains numerous genes, and ATP5MD occupies a relatively compact genomic space consistent with its small coding sequence. The gene encodes a protein of only 58 amino acids, making it one of the smaller subunits of the ATP synthase complex. Like other nuclear-encoded mitochondrial proteins, the ATP5MD transcript is synthesised in the cell's cytoplasm and the resulting protein must be imported into mitochondria through specialised targeting mechanisms.

Protein structure

Domain architecture has not been experimentally characterised in detail for this protein. The ATP5MD protein consists of 58 amino acids and is predicted to contain transmembrane regions that anchor it within the lipid bilayer of the mitochondrial inner membrane. Its compact size suggests it serves primarily a structural or stabilising role within the larger ATP synthase assembly rather than performing catalytic functions directly. Membrane-spanning subunits like ATP5MD typically adopt alpha-helical conformations that traverse the lipid environment, contributing to the formation of the proton channel through which hydrogen ions flow during ATP synthesis.

Key variants

Genetic variants in ATP5MD have not been extensively characterised in the literature, reflecting both the relatively recent identification of this gene and its small coding sequence. The compact nature of the gene means that even single nucleotide changes could potentially affect the protein's ability to integrate into the ATP synthase complex or maintain its structural role. Pathogenic variants in genes encoding ATP synthase subunits can disrupt mitochondrial energy production, though the clinical significance of variants in ATP5MD specifically remains an area requiring further research.

No pathogenic or likely-pathogenic ClinVar variants recorded yet for this gene.

Associated conditions

No specific inherited conditions have been definitively linked to pathogenic variants in ATP5MD in clinical databases. Mitochondrial disorders arising from defects in ATP synthase subunits generally present with multisystem features, often affecting tissues with high energy demands such as brain, heart, and skeletal muscle. As research into mitochondrial genetics advances, it is possible that variants in ATP5MD may be identified in individuals with unexplained mitochondrial dysfunction. However, at present, the gene's role in human disease remains uncertain.

No disease links recorded for this gene in our reference set.

UK clinical status

Frequently asked questions

What does the ATP5MD protein do?

The ATP5MD protein is a small membrane-spanning component of ATP synthase, the enzyme complex that produces ATP in mitochondria. It contributes to the structural organisation of the membrane-embedded portion of the complex, helping to maintain the architecture necessary for efficient energy production.

Why is ATP synthase important?

ATP synthase generates most of the ATP that cells use as their primary energy source. This molecule powers virtually all cellular activities, from muscle contraction and nerve transmission to biosynthesis of proteins and DNA. Without functional ATP synthase, cells cannot meet their energy requirements.

Are there known diseases linked to ATP5MD variants?

Currently, no specific inherited conditions have been definitively associated with pathogenic variants in ATP5MD. Research into mitochondrial genetics continues to evolve, and it is possible that disease associations may be identified as more individuals undergo genomic testing.

Educational content. This page is not medical or genetic advice, is not individually reviewed by a clinician for each reader, and should not replace a consultation with a qualified healthcare professional or genetic counsellor. If you are considering genetic testing or acting on a test result, book a consultation.
Data sources Last updated 17 April 2026. Content compiled from HGNC · MedlinePlus Genetics · ClinGen · Genomics England PanelApp · NHS National Genomic Test Directory · ClinVar · UniProt · AlphaFold .